CNTX Context Therapeutics Inc
Company Analysis
Latest News
🟢 Context Therapeutics Inc is trading 5.2% up today on bargain-hunting after a sharp selloff
Context Therapeutics Inc is trading 5.2% up at $0.63 as shares see a modest rebound following several days of heavy losses linked to clinical trial results. •...
Context Therapeutics Called Its Cancer Data "Positive" — So Why Have Investors Wiped Out 59% of Its Stock in Three Days?
Shares of Context Therapeutics cratered this week after the company released interim Phase 1 results for its lead ovarian cancer drug, raising a brutal...
🔴 Context Therapeutics Inc is trading 8% down today on follow-through selling after CTIM-76 data release
Context Therapeutics Inc is trading at $0.60 (8% down) as the stock extends its sharp decline following the release of interim Phase 1 data for its ovarian...
🔴 Context Therapeutics Inc is trading 5.3% down today, extending a sell-off after Phase 1 data for ovarian cancer candidate CTIM-76
Context Therapeutics Inc is trading at $0.64 (5.3% down), extending a sharp sell-off triggered by interim Phase 1 data for its ovarian cancer candidate,...
🔴 Context Therapeutics Inc is trading 6.4% down today as profit-taking continues after CTIM-76 data
Context Therapeutics Inc is trading at $0.64 (6.4% down) in pre-market, extending a sharp sell-off following the release of interim Phase 1 data for its...
Context Therapeutics Reports Positive Phase 1 Data for CTIM-76 in Ovarian Cancer
Context Therapeutics Inc. announced positive interim efficacy and safety results from its ongoing Phase 1 clinical trial of CTIM-76, its investigational...
🔴 Context Therapeutics Inc is trading 34.68% down today after a sharp intraday selloff
Context Therapeutics Inc is trading at $0.91 (-34.68%) following a sharp intraday selloff, though no specific company catalyst has been confirmed to drive the...
🟢 Context Therapeutics Inc makes sharp 12.2% jump
CNTX is trading at $1.56, up 12.2% versus the comparison close of $1.39 during pre-market. This is a price-movement alert; no separate company-specific...
🟢 Context Therapeutics Inc Up 5.4% on Positive Interim Phase 1 CTIM-76 Data & Nasdaq Compliance
Context Therapeutics Inc is trading 5.4% higher at $1.46 in pre-market. This follows the announcement of positive interim Phase 1 clinical data for its CTIM-76...
🟢 Context Therapeutics Inc is trading 13.8% up today with no clear catalyst identified
Context Therapeutics Inc is trading at $1.73, up 13.8% in after-hours trading, with no clear fundamental catalyst identified to explain the price action. *...
🟢 Context Therapeutics Inc is trading 7.9% up today with no clear catalyst found
Context Therapeutics Inc is trading 7.9% up at $1.64 following the June 9 regular session close, despite a lack of company-specific news or announcements to...
🔴 Context Therapeutics Inc is trading 10.2% down today, extending a multi-day decline on weak momentum
Context Therapeutics Inc is trading 10.2% down today at $1.53, continuing a steep downward trend that has seen the stock fall from $2.85 on May 29, 2026. •...
🔴 Context Therapeutics Inc is trading 8.48% down today amid a multi-day slide and broader risk-off sentiment
Context Therapeutics Inc is trading 8.48% down at $1.56 today, extending a sharp multi-day decline amid weak momentum and broader risk-off sentiment in the...
🔴 Context Therapeutics Inc is trading 6.4% down today, extending a multi-day slide amid high volatility
Context Therapeutics Inc is trading 6.4% down today at $1.60, extending a sharp multi-day decline amid light newsflow and recent high volatility. • The move...
🔴 Context Therapeutics Inc is trading 11.4% down today amid a broad biotech selloff and hawkish rate expectations
Context Therapeutics Inc is trading 11.4% down at $2.00 following a sharp session decline driven by a broad market selloff rather than company-specific...
🔴 Context Therapeutics Inc is trading 10.84% down today amid broader market pressure and hawkish rate expectations
Context Therapeutics Inc is trading 10.84% down at $1.81 as broader market pressure weighs heavily on the biotechnology sector. • The move appears tied to a...
🔴 Context Therapeutics Inc is trading 5.2% down today amid broader biotech sector weakness
Context Therapeutics Inc is trading 5.2% down at $1.93 today as the stock continues a multi-day slide amid broader risk-off pressure hitting growth and...
🟢 Context Therapeutics Inc is trading 7.1% up today on a technical bounce after consecutive double-digit declines
Context Therapeutics Inc is trading up 7.1% at $2.19 as traders position for a short-term rebound following a period of heavy selling. • The move comes after...
🟢 Context Therapeutics Inc is trading 6.8% up today on a potential technical bounce after recent declines
Context Therapeutics Inc is trading 6.8% up today at $2.19 as the stock appears to be staging a technical bounce or attracting bargain hunters following two...
🔴 Context Therapeutics Inc is trading 10.9% down today as traders lock in profits after recent rally
Context Therapeutics Inc is trading 10.9% down at $2.48 as investors lock in gains following a sharp multi-day rally. • The stock recently surged from...